Global Peritoneal Dialysis Equipment Market Strategic Research Report

The global peritoneal dialysis (PD) equipment market represents a critical segment within the broader renal replacement therapy industry, addressing the clinical needs of patients with end-stage renal disease (ESRD) and chronic kidney disease (CKD) who elect home-based or clinic-based dialysis alternatives to hemodialysis. Valued at approximately USD 4.1 billion in 2024, the market encompasses automated peritoneal dialysis (APD) cyclers, continuous ambulatory peritoneal dialysis (CAPD) systems, PD solutions, transfer sets, catheters, and associated disposables. With the global ESRD patient population estimated to exceed 3.9 million and rising at a rate outpacing treatment infrastructure in many emerging economies, PD equipment has emerged as a commercially significant and medically essential product category commanding sustained institutional investment.

The market's growth trajectory is shaped by three converging forces. First, national reimbursement policies in high-income markets such as the United States, Australia, and the United Kingdom have increasingly favored home dialysis modalities, with CMS-aligned incentive structures in the U.S. pushing providers toward PD prescription for eligible patients — directly expanding equipment procurement volumes. Second, the epidemiological expansion of diabetes and hypertension across South and East Asia, two of the most prevalent causal pathways to CKD, is generating a rapid increase in the incident ESRD population in China, India, and Southeast Asia, where infrastructure for home PD adoption remains underdeveloped but is receiving government prioritization. Third, technological advancement in APD cycler design — particularly miniaturized, IoT-connected devices enabling remote patient monitoring — is improving clinical outcomes and reducing hospitalization rates, creating persuasive health-economic arguments for payer adoption. The principal restraint acting on market expansion is the persistent shortage of trained nephrologists and PD nurses in low- and middle-income countries, which limits patient initiation rates and increases the risk of peritonitis-related treatment dropout.

This report provides a comprehensive assessment of the global peritoneal dialysis equipment market across the 2025–2032 forecast period, anchored to a 2024 base year. It segments the market by equipment type, application, and geography — covering five regions and six key country-level markets — and profiles ten major competing companies in detail. The report is designed for corporate strategy teams evaluating portfolio expansion, investment analysts conducting sector due diligence, M&A advisors assessing acquisition targets within the renal care value chain, and procurement managers benchmarking supplier capabilities.